Chinese medicinal composition for treating chronic myeloid leukemia

Abstract

The invention relates to a Chinese medicinal composition for treating chronic myeloid leukemia, which consists of the following components: 15 to 25 grams of rehmanniae praeparatum, 8 to 16 grams of tree peony bark, 18 to 28 grams of honey-fried extract glycyrrhiza, 18 to 32 grams of spreading hedyotis herb, 14 to 20 grams of lalang grass rhizome, 18 to 28 grams of glossy privet fruit, 14 to 28 grams of desertliving cistanche, 4 to 8 grams of cordyceps sinensis, 12 to 20 grams of Indian iphigenia bulb, 8 to 16 grams of stiff silkworm and 8 to 16 grams of eupolyphaga. The Chinese medicinal composition can carry out pertinence treatment on chronic myeloid leukemia, selectively inhibits and kills immature cells, induces apoptosis of leukemia cells, has strong pertinence and better treatment effect, promotes differentiation and maturation of leukemia cells, regulates qi and blood, strengthens the immunity, promotes recovery of the normal hematopoietic function of bone marrow, reduces reversion, prevents tolerance from being generated, reduces the toxic or side effects of chemotherapy and strengthens physical fitness.

Description

technical field [0001] The invention relates to a medicine for treating leukemia, in particular to a traditional Chinese medicine composition for treating chronic myeloid leukemia. Background technique [0002] Leukemia is A malignant clonal disease of hematopoietic stem cells, characterized by the diffuse proliferation of abnormal white blood cells (leukemic cells) in the bone marrow to replace normal bone marrow tissue and invade the surrounding blood, resulting in quantitative and qualitative changes in the white blood cells in the peripheral blood. The number of white blood cells in the blood is often significantly increased, but sometimes it can be normal or even decreased. Leukemic cells can extensively infiltrate various tissues and organs throughout the body, such as the liver, spleen, and lymph nodes, and often cause anemia and hemorrhage. [0003] According to the statistics of the Ministry of Health, in 2009, the annual incidence rate of leukemia in my country ...

AI Technical Summary

Problems solved by technology

However, this method has great side effects, such as killing and inhibiting normal hematopoietic stem cells, causing anemia and bleeding, suppressing normal immune function, reducing body immunity, and easily merging with various infections, damaging the gastrointestinal mucosa, leading to anorexia, nausea, and vomiting. Affects heart, liver and kidney functions. No matter how high the dose is, it is impossible to completely kill the white blood cells in the body, and the residual leukemia cells are the root cause of disease recurrence.

This not only brings great pain to the patients themselves, but also causes heavy mental burden and economic losses to their families and society.